Given that, in the Italian specialist care setting, patients with T2D who are not on insulin are seen every 6–9 months, we assume that most patients were recommended to self-titrate to 7 mg after one month of therapy with the 3 mg dose, but that the titration to 14 mg was suggested after the follow-up visit. The gene discussed is INS; the disease is type 2 diabetes mellitus.